KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Invested Capital (2016 - 2026)

Quest Diagnostics' Invested Capital history spans 18 years, with the latest figure at $8.2 billion for Q1 2026.

  • On a quarterly basis, Invested Capital rose 13.82% to $8.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.2 billion, a 13.82% increase, with the full-year FY2025 number at $12.8 billion, down 1.45% from a year prior.
  • Invested Capital hit $8.2 billion in Q1 2026 for Quest Diagnostics, down from $12.8 billion in the prior quarter.
  • Over the last five years, Invested Capital for DGX hit a ceiling of $13.1 billion in Q3 2024 and a floor of $6.1 billion in Q1 2023.
  • Historically, Invested Capital has averaged $8.5 billion across 5 years, with a median of $7.4 billion in 2024.
  • Biggest five-year swings in Invested Capital: surged 93.47% in 2024 and later crashed 40.71% in 2025.
  • Tracing DGX's Invested Capital over 5 years: stood at $9.9 billion in 2022, then increased by 11.55% to $11.1 billion in 2023, then rose by 17.87% to $13.0 billion in 2024, then decreased by 1.45% to $12.8 billion in 2025, then plummeted by 36.38% to $8.2 billion in 2026.
  • Business Quant data shows Invested Capital for DGX at $8.2 billion in Q1 2026, $12.8 billion in Q4 2025, and $7.8 billion in Q3 2025.